Cowen Inc’s Halozyme HALO Stock Holding History

Cowen Inc’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-2,000	Closed	-$26K	–	334
2017 Q1	$26K	Buy	+2,000	New	+$25.3K	﹤0.01%	226
2014 Q3	–	Sell	-15,800	Closed	-$156K	–	310
2014 Q2	$156K	Hold	15,800	–	–	0.02%	224
2014 Q1	$201K	Buy	+15,800	New	+$235K	0.02%	175

Other funds holding HALO

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SAM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cowen Inc's HALO Position: Q2 2017 in Review

Cowen Inc sold out of Halozyme (HALO) in Q2 2017, closing a stake of 2,000 shares — an estimated $26K sold.

Cowen Inc first reported a position in HALO in Q1 2014 and held it in 3 quarters. The position peaked at $201K in Q1 2014. 167 funds tracked by Wall St. Rank hold HALO as of Q2 2017.

Cowen Inc reported no remaining Halozyme position as of Q2 2017 after selling out during the quarter.
Cowen Inc sold 2,000 Halozyme shares in Q2 2017, an estimated $26K.
Cowen Inc first reported a position in Halozyme in Q1 2014 and held it in 3 quarters.
Cowen Inc's Halozyme position peaked at $201K in Q1 2014.
167 funds tracked by Wall St. Rank held Halozyme as of Q2 2017.

Based on Cowen Inc's 13F filing for Q2 2017, filed 10 Aug 2017.